Affymetrix Says Thermo Fisher Deal Still Beats Ex-Execs'
Genetic analysis biotech Affymetrix again spurned a buyout offer from several former executives in favor of a planned acquisition by Thermo Fisher, contending Monday that the sweetened bid, which is being...To view the full article, register now.
Already a subscriber? Click here to view full article